Colorectal cancer in the young: a possible role for immune surveillance?

Acta Chirurgica Belgica

Volumn 118, Issue 1, 2018, Pages 7-14

  Fiorot, Alain ^a   Pozza, Anna ^a   Ruffolo, Cesare ^a   Caratozzolo, Ezio ^a   Bonariol, Luca ^a   D’Amico, Francesco Enrico ^a   Padoan, Luigi ^a   Calia di Pinto, Francesco ^a   Scarpa, Marco ^b   Castoro, Carlo ^b   Bassi, Nicolò ^a   Massani, Marco ^a  

^a Regional Hospital C Foncello   (Italy)

^b VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

Author keywords

Colorectal cancer; immonosurveillance; survival; young age

Indexed keywords

ADENOCARCINOMA; ADULT; AGE; AGED; CANCER STAGING; COHORT ANALYSIS; COLON RESECTION; COLORECTAL TUMOR; COMPARATIVE STUDY; DISEASE FREE SURVIVAL; FEMALE; HUMAN; IMMUNOCOMPETENCE; IMMUNOLOGICAL PROCEDURES; IMMUNOLOGY; MALE; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PATHOLOGY; PHYSIOLOGY; PREDICTIVE VALUE; PROCEDURES; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; RISK ASSESSMENT; ROLE PLAYING; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR INVASION;

ADENOCARCINOMA; ADULT; AGE FACTORS; AGED; COHORT STUDIES; COLECTOMY; COLORECTAL NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IMMUNOCOMPETENCE; IMMUNOLOGIC TESTS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; ROC CURVE; ROLE; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 85026257813     PISSN: 00015458     EISSN: 25770160     Source Type: Journal    
DOI: 10.1080/00015458.2017.1353233     Document Type: Article

References (46)

1. Inra JA, Syngal S., Colorectal cancer in young adults. Dig Dis Sci. 2015;60:722–733. [Internet]. Available from: http://link.springer.com/10.1007/s10620-014-3464-0
2. Siegel R, Miller K, Jemal A., Cancer statistics, 2015. CA Cancer J Clin [Internet]. 2015;65:29. Available from: http://onlinelibrary.wiley.com/doi/10.3322/caac.21254/pdf
3. Schellerer VS, Merkel S, Schumann SC, et al. Despite aggressive histopathology survival is not impaired in young patients with colorectal cancer: CRC in patients under 50 years of age. Int J Colorectal Dis. 2012;27:71–79.
4. Taggarshe D, Rehil N, Sharma S, et al. Colorectal cancer: are the “young” being overlooked?. Am J Surg. 2013;205:312–316.
5. Abdelsattar ZM, Wong SL, Regenbogen SE, et al. Colorectal cancer outcomes and treatment patterns in patients too young for average-risk screening. Cancer. 2016;122:929–934.
6. Patel P, De P., Trends in colorectal cancer incidence and related lifestyle risk factors in 15–49-year-olds in Canada, 1969–2010. Cancer Epidemiol. 2016;42:90–100. [Internet]. Available from: http://www.sciencedirect.com/science/article/pii/S1877782116300340
7. Young JP, Win AK, Rosty C, et al. Rising incidence of early-onset colorectal cancer in Australia over two decades: report and review. J. Gastroenterol. Hepatol. 2015;30:6–13.
8. Austin H, Jane Henley S, King J, et al. Changes in colorectal cancer incidence rates in young and older adults in the United States: what does it tell us about screening. Cancer Causes Control. 2014;25:191–201. [Internet]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24249437\nhttp://link.springer.com/10.1007/s10552-013-0321-y
9. Bailey CE, Hu C-Y, You YN, et al. Increasing disparities in the age-related incidences of colon and rectal cancers in the United States, 1975–2010. JAMA Surg. 2015;150:17–22.
10. Cooley EK, McPhee JT, Simons JP, et al. Colorectal neoplasia screening before age 50?: current epidemiologic trends in the United States. Dis Colon Rectum. 2009;52:222–229.
11. O’Connell JB, Maggard MA, Livingston EH, et al. Colorectal cancer in the young. Am. J. Surg 2004;187:343–348.
12. Savas N, Dagli U, Akbulut S, et al. Colorectal cancer localization in young patients: Should we expand the screening program? Dig Dis Sci. 2007;52:798–802.
13. Li M, Li J-Y, Zhao A-L, et al. Do young patients with colorectal cancer have a poorer prognosis than old patients?. J Surg Res.[Internet]. 2011;167:231–236. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21316708
14. Chew M-H, Koh P-K, Ng K-H, et al. Improved survival in an Asian cohort of young colorectal cancer patients: an analysis of 523 patients from a single institution. Int J Colorectal Dis. 2009;24:1075–1083. [Internet]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19387661
15. Chiang JM, Chen MC, Changchien CR, et al. Favorable influence of age on tumor characteristics of sporadic colorectal adenocarcinoma: patients 30 years of age or younger may be a distinct patient group. Dis Colon Rectum. 2003;46:904–910.
16. Chung YF, Eu KW, Machin D, et al. Young age is not a poor prognostic marker in colorectal cancer. Br J Surg. 1998;85:1255–1259. [Internet]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9752871
17. Yeo SA, Chew MH, Koh PK, et al. Young colorectal carcinoma patients do not have a poorer prognosis: A comparative review of 2,426 cases. Tech Coloproctol. 2013;17:653–661.
18. Pagès F, Berger A, Camus M, et al. Effector memory T cells, early metastasis, and survival in colorectal cancer. N Engl J Med. 2005;353:2654–2666. [Internet]. Available from: ://WOS:000234094400006\nhttp://www.nejm.org/doi/pdf/10.1056/NEJMoa051424\nhttp://www.ncbi.nlm.nih.gov/pubmed/16371631.
19. Kubo H, Murayama Y, Arita T, et al. The prognostic value of preoperative neutrophil-to-lymphocyte ratio in colorectal cancer. World J. Surg. 2016;40:2796–2802.
20. Halling KC, French AJ, McDonnell SK, et al. Microsatellite instability and 8p allelic imbalance in stage B2 and C colorectal cancers. J Natl Cancer Inst. 1999;91:1295–1303.
21. Lanza G, Gafa R, Santini A, et al. Immunohistochemical test for MLH1 and MSH2 expression predicts clinical outcome in stage II and III colorectal cancer patients. J Clin Oncol. 2006;24:2359–2367.
22. Samowitz WS, Curtin K, Ma KN, et al. Microsatellite instability in sporadic colon cancer is associated with an improved prognosis at the population level. Cancer Epidemiol Biomarkers Prev. 2001;10:917–923.
23. Popat S, Hubner R, Houlston RS., Systematic review of microsatellite instability and colorectal cancer prognosis. J Clin Oncol. 2005;23:609–618.
24. Malesci A, Laghi L, Bianchi P, et al. Reduced likelihood of metastases in patients with microsatellite-unstable colorectal cancer. Clin Cancer Res. 2007;13:3831–3839.
25. Van Cutsem EJD., Colon cancer: ESMO clinical recommendations for diagnosis, adjuvant treatment and follow-up. Ann Oncol. 2007;18 Suppl 2:ii21–ii22.
26. Scarpa M, Brun P, Scarpa M, et al. CD80-CD28 signaling controls the progression of inflammatory colorectal carcinogenesis. Oncotarget. 2015;6:20058–20069.
27. Scarpa M, Ruffolo C, Canal F, et al. Mismatch repair gene defects in sporadic colorectal cancer enhance immune surveillance. Oncotarget. 2015;6:43472–82. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26496037
28. Llosa NJ, Cruise M, Tam A, et al. The vigorous immune microenvironment of microsatellite instable colon cancer is balanced by multiple counter-inhibitory checkpoints. Cancer Discov. 2015;5:43–51.
29. Karlitz JJ, Hsieh M-C, Liu Y, et al. Population-based lynch syndrome screening by microsatellite instability in patients
30. ®) Colon Cancer [Internet]. Version 2.2016. 2016. p. 1–159. Available from: http://www.NCCN.com
31. Ballester V, Rashtak S, Boardman L., Clinical and molecular features of young-onset colorectal cancer. World J Gastroenterol. 2016;22:1736–1744.
32. Gupta S, Bhattacharya D, Acharya a. N, et al. Colorectal carcinoma in young adults: a retrospective study on Indian patients: 2000–2008. Colorectal Dis. 2010;12:e182–e189.
33. Kim TJ, Kim ER, Hong SN, et al. Long-term outcome and prognostic factors of sporadic colorectal cancer in young patients: a large institutional-based retrospective study. Medicine (Baltimore). 2016;95:e3641.
34. Aronson M, Holter S, Semotiuk K, et al. DNA mismatch repair status predicts need for future colorectal surgery for metachronous neoplasms in young individuals undergoing colorectal cancer resection. Dis. Colon Rectum. 2015;58:645–652.
35. Liang J, Kalady MF, Church J., Young age of onset colorectal cancers. Int J Colorectal Dis. 2015;30:1653–1657.
36. Quah HM, Joseph R, Schrag D, et al. Young age influences treatment but not outcome of colon cancer. Ann Surg Oncol. 2007;14:2759–2765.
37. O’Connell JB, Maggard MA, Liu JH, et al. Do young colon cancer patients have worse outcomes? World J Surg. 2004;28:558–562.
38. Wang R, Wang M-J, Ping J., Clinicopathological features and survival outcomes of colorectal cancer in young versus elderly: a population-based cohort study of SEER 9 registries data (1988–2011). Medicine (Baltimore). 2015;94:e1402.
39. Li G, Smithey MJ, Rudd BD, et al. Age-associated alterations in CD8alpha + dendritic cells impair CD8 T-cell expansion in response to an intracellular bacterium. Aging Cell. 2012;11:968–977.
40. Solana R, Tarazona R, Gayoso I, et al. Innate immunosenescence: effect of aging on cells and receptors of the innate immune system in humans. Semin Immunol. 2012;24:331–341.
41. Haynes L, Swain SL., Aged-related shifts in T cell homeostasis lead to intrinsic T cell defects. Semin Immunol. 2012;24:350–355.
42. Nikolich-Zugich J, Li G, Uhrlaub JL, et al. Age-related changes in CD8 T cell homeostasis and immunity to infection. Semin Immunol. 2012;24:356–364.
43. Absenger G, Szkandera J, Pichler M, et al. A derived neutrophil to lymphocyte ratio predicts clinical outcome in stage II and III colon cancer patients. Br J Cancer. 2013;109:395–400.
44. Kao SCH, Pavlakis N, Harvie R, et al. High blood neutrophil-to-lymphocyte ratio is an indicator of poor prognosis in malignant mesothelioma patients undergoing systemic therapy. Clin Cancer Res. 2010;16:5805–5813.
45. Raungkaewmanee S, Tangjitgamol S, Manusirivithaya S, et al. Platelet to lymphocyte ratio as a prognostic factor for epithelial ovarian cancer. J Gynecol Oncol. 2012;23:265–273.
46. Szkandera J, Gerger A, Liegl-Atzwanger B, et al. The lymphocyte/monocyte ratio predicts poor clinical outcome and improves the predictive accuracy in patients with soft tissue sarcomas. Int J Cancer. 2014;135:362–370.